- These Stocks Have Been Left Behind in the Rally. They May Be Ripe for Picking. (Barron’s)
- Here’s What Happens Now That Oxford-AstraZeneca Vaccine Won U.K. Clearance (Bloomberg)
- Biotech Stocks Ready for More Covid-19 Results in First Quarter (Bloomberg)
- A Stretch of Pristine Land in Florida Is Finally Booming During Covid (Bloomberg)
- Warren Buffett paid out $60 million after the Red Sox won the World Series in 2007 (Business Insider)
- Here’s the difference between the dot-com bubble and today’s soaring stock market, according to DataTrek (Business Insider)
- The Vaccine Dominated 2020 for J&J. Next Year Should Be More Normal. (Barron’s)
- Bitcoins Dirty Little Secret. The Energy Report 12/30/2020 (Phil Flynn)
- Regeneron COVID-19 Antibody Cocktail Shows Positive Response In Hospitalized Patients (Benzinga)
- Third Point Urges Intel To Explore Strategic Alternatives: Report (Benzinga)
- These are the 20 worst-performing S&P 500 stocks of 2020 — analysts see double-digit rebounds for 6 of them in 2021 (MarketWatch)
- Fed, Treasury Provide One-Week Reprieve for ‘Main Street’ Program After Demand Surges (Wall Street Journal)
- Lamborghini, Maserati, Mini, T-Bucket: Our Favorite My Ride Cars of 2020 (Wall Street Journal)
- Inside the Google-Facebook Ad Deal at the Heart of a Price-Fixing Lawsuit (Wall Street Journal)
- Covid-19 Vaccine Outlook Prompts Businesses to Dust Off Return-to-Office Plans (Wall Street Journal)